Food and Drug Administration official to discuss the future of the Covid-19 vaccines in United States
Food and Drug Administration vaccine experts are getting together on Thursday to talk about the future of the COVID-19 vaccine in the United States.
The U.S. currently offers two kinds of COVID-19 vaccines: a primary series of shots and booster shots. But many changes have made the system harder to use.
Only 15% of Americans have had a booster shot, even though nearly 70% of them have had their first shots.
FDA advisors are thinking about making COVID-19 shots like the flu shot, which are given once a year.
Most likely, the shot would protect against more than one strain of the virus. Only people with weak immune systems would be told to get a second shot.
The committee will also look at how well the booster shots are working right now.
A study from the Centers for Disease Control and Prevention found that boosters cut the risk of infection by about half and protect even more against serious illness and death.
